IDH1 and central nervous system cancer: This is the case of mutations in IDH1 or IDH2 in lower-grade gliomas, and histone 3 (H3F3A and HIST1H3B) mutations in pediatric high-grade gliomas that are also associated with specific patterns of DNA methylation [70].